Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Yoshitomo Chujoh"'
1
Akademický článek
Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
Autor: Toshifumi Hibi, Makoto Naganuma, Eisei Oda, Yoji Yamada, Yoshitomo Chujoh, Ryoichi Yoshihara, Mamoru Watanabe
Publikováno v: Intestinal Research, Vol 18, Iss 1, Pp 56-68 (2020)
Background/Aims Mucosal healing (MH) of distal lesions in ulcerative colitis (UC) has recently been confirmed with budesonide 2-mg foam (BF) treatment in 2 clinical trials; however, few studies have investigated the predictive factors for complete MH
Externí odkaz: https://doaj.org/article/eb7600b0981244ccb613827576d40c22
Zobrazit plný text záznamu
2
Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
Autor: Mamoru Watanabe, Yoshitomo Chujoh, Toshifumi Hibi, Ryoichi Yoshihara, Eisei Oda, Yoji Yamada, Makoto Naganuma
Publikováno v: Intestinal Research, Vol 18, Iss 1, Pp 56-68 (2020)
Intestinal Research
Background/Aims: Mucosal healing (MH) of distal lesions in ulcerative colitis (UC) has recently been confirmed with budesonide 2-mg foam (BF) treatment in 2 clinical trials; however, few studies have investigated the predictive factors for complete M
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf5a550486ae83914753db5f24d0ed4
https://doi.org/10.5217/ir.2019.00064
Zobrazit plný text záznamu
3
Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B′ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine
Autor: Satoshi Naganawa, Shinji Haga, Tetsuya Nakasatomi, Kenji Someya, Yoshitomo Chujoh, Hitomi Yoshizaki, Kazuhiro Matsuo, Hiroshi Yoshikura, Mitsuo Honda, Yukari Okamoto, Shudo Yamazaki, Akihiro Yamazaki
Publikováno v: Vaccine. 20:797-804
The recombinant Mycobacterium bovis BCG (rBCG) vector-based vaccine secreting the V3 principal neutralizing epitope of human immunodeficiency virus type 1 (HIV-1) Japanese strain was reported to induce both humoral and cellular immune responses effec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b885c580078fd7caab4a8281400040c
https://doi.org/10.1016/s0264-410x(01)00398-x
Zobrazit plný text záznamu
4
Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis
Autor: Kunitada Shimotohno, Katsuaki Tanaka, Yasushi Shiratori, Takashi Sakaguchi, Masaaki Ibe, Yoshitomo Chujoh, Kiyoshi Miwa, Torahiko Tanaka, Masafumi Takiguchi, Satoru Saito, Shumpei Yokota, Masao Omata
Publikováno v: Journal of General Virology. 79:1735-1744
In order to clarify the role of cytotoxic T lymphocytes (CTL) in hepatitis C virus (HCV) infection, an HLA-B35-restricted cytotoxic T cell epitope of HCV was identified using a strategy called reverse immunogenetics. Twenty-eight of 53 HCV peptides c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba530f78939848e6dd7b69067f8b4421
https://doi.org/10.1099/0022-1317-79-7-1735
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje